These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9581865)

  • 21. TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants.
    Orgad S; Dimant H; Dor-On E; Azriel-Rosenfeld R; Benhar I; Solomon B
    J Immunother; 2010; 33(2):146-54. PubMed ID: 20139776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 is involved in the p120E4F-mediated growth arrest.
    Sandy P; Gostissa M; Fogal V; Cecco LD; Szalay K; Rooney RJ; Schneider C; Del Sal G
    Oncogene; 2000 Jan; 19(2):188-99. PubMed ID: 10644996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of the DNA-binding-induced loop L1 conformational switch in an engineered human p53 protein.
    Emamzadah S; Tropia L; Vincenti I; Falquet B; Halazonetis TD
    J Mol Biol; 2014 Feb; 426(4):936-44. PubMed ID: 24374182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
    Takimoto R; El-Deiry WS
    Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro analysis of the dominant negative effect of p53 mutants.
    Chène P
    J Mol Biol; 1998 Aug; 281(2):205-9. PubMed ID: 9698540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of mutant p53 using field-effect transistor biosensor.
    Han SH; Kim SK; Park K; Yi SY; Park HJ; Lyu HK; Kim M; Chung BH
    Anal Chim Acta; 2010 Apr; 665(1):79-83. PubMed ID: 20381694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.
    Di Como CJ; Prives C
    Oncogene; 1998 May; 16(19):2527-39. PubMed ID: 9627118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning and characterization of murine p53 upstream sequences reveals additional positive transcriptional regulatory elements.
    Reisman D; Eaton E; McMillin D; Doudican NA; Boggs K
    Gene; 2001 Aug; 274(1-2):129-37. PubMed ID: 11675005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.
    Merabet A; Houlleberghs H; Maclagan K; Akanho E; Bui TT; Pagano B; Drake AF; Fraternali F; Nikolova PV
    Biochem J; 2010 Mar; 427(2):225-36. PubMed ID: 20113312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53-associated 3'-->5' exonuclease activity in nuclear and cytoplasmic compartments of cells.
    Lilling G; Elena N; Sidi Y; Bakhanashvili M
    Oncogene; 2003 Jan; 22(2):233-45. PubMed ID: 12527892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct Rayleigh scattering from hot spot mutant p53 proteins reveals cancer cells.
    Jun HJ; Nguyen AH; Kim YH; Park KH; Kim D; Kim KK; Sim SJ
    Small; 2014 Jul; 10(14):2954-62. PubMed ID: 24700814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DNA binding domain is contained in the C-terminus of wild type p53 protein.
    Foord OS; Bhattacharya P; Reich Z; Rotter V
    Nucleic Acids Res; 1991 Oct; 19(19):5191-8. PubMed ID: 1923804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of mutant p53 expression on human 15-lipoxygenase-promoter activity and murine 12/15-lipoxygenase gene expression: evidence that 15-lipoxygenase is a mutator gene.
    Kelavkar UP; Badr KF
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4378-83. PubMed ID: 10200270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
    Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
    Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of p53 transactivation through high-affinity binding sites.
    Chumakov AM; Miller CW; Chen DL; Koeffler HP
    Oncogene; 1993 Nov; 8(11):3005-11. PubMed ID: 8414502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen.
    Friedman PN; Kern SE; Vogelstein B; Prives C
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9275-9. PubMed ID: 2174557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation.
    Reed M; Woelker B; Wang P; Wang Y; Anderson ME; Tegtmeyer P
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9455-9. PubMed ID: 7568153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 domains: identification and characterization of two autonomous DNA-binding regions.
    Wang Y; Reed M; Wang P; Stenger JE; Mayr G; Anderson ME; Schwedes JF; Tegtmeyer P
    Genes Dev; 1993 Dec; 7(12B):2575-86. PubMed ID: 8276240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.